Reliability of instrumented movement analysis as outcome measure in Charcot-Marie-Tooth disease: Results from a multitask locomotor protocol

Gait and Posture

Volumn 34, Issue 1, 2011, Pages 36-43

  Ferrarin, M ^a   Bovi, G ^a   Rabuffetti, M ^a   Mazzoleni, P ^a   Montesano, A ^a   Moroni, I ^b   Pagliano, E ^b   Marchi, A ^b   Marchesi, C ^b   Beghi, E ^c   Pareyson, D ^b  

^a IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

^b DEPARTMENT OF NEUROSURGERY   (Italy)

^c MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Charcot Marie Tooth disease; Gait analysis; Heel walking; Outcome measures; Reliability; Step ascending descending; Toe walking

Indexed keywords

ADOLESCENT; ADULT; AGED; ANKLE; ARTICLE; CHILD; CLINICAL ARTICLE; DEGENERATIVE DISEASE; ELECTROMYOGRAM; FEMALE; GAIT; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; LOCOMOTION; MALE; PRIORITY JOURNAL; RELIABILITY; WALKING;

ADOLESCENT; ADULT; AGED; BIOMECHANICS; CHARCOT-MARIE-TOOTH DISEASE; CHILD; ELECTROMYOGRAPHY; FEMALE; GAIT DISORDERS, NEUROLOGIC; HUMANS; LOCOMOTION; MALE; MIDDLE AGED; RANGE OF MOTION, ARTICULAR; REPRODUCIBILITY OF RESULTS;

EID: 79957524474     PISSN: 09666362     EISSN: 18792219     Source Type: Journal    
DOI: 10.1016/j.gaitpost.2011.03.007     Document Type: Article

References (26)

1. Martyn C.N., Hughes R.A. Epidemiology of peripheral neuropathy. J Neurol Neurosurg Psychiatry 1997, 62(April (4)):310-318.
2. Pareyson D., Marchesi C. Diagnosis, natural history, and management of Charcot-Marie-Tooth disease. Lancet Neurol 2009, 8(July (7)):654-667.
3. Pareyson D., Schenone A., Fabrizi G.M., Santoro L., Padua L., Quattrone A., et al. A multicenter, randomized, double-blind, placebo-controlled trial of long-term ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL): the study protocol [EudraCT no.: 2006-000032-27]. Pharmacol Res 2006, 54(December (6)):436-441.
4. Burns J., Ouvrier R.A., Yiu E.M., Joseph P.D., Kornberg A.J., Fahey M.C., et al. Ascorbic acid for Charcot-Marie-Tooth disease type 1A in children: a randomised, double-blind, placebo-controlled, safety and efficacy trial. Lancet Neurol 2009, 8(June (6)):537-544.
5. Micallef J., Attarian S., Dubourg O., Gonnaud P.M., Hogrel J.Y., Stojkovic T., et al. Effect of ascorbic acid in patients with Charcot-Marie-Tooth disease type 1A: a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol 2009, 8(December (12)):1103-1110.
6. Newman C.J., Walsh M., O'Sullivan R., Jenkinson A., Bennett D., Lynch B., et al. The characteristics of gait in Charcot-Marie-Tooth disease types I and II. Gait Posture 2007, 26:120-127.
7. Don R., Serrao M., Vinci P., Ranavolo A., Cacchio A., Ioppolo F., et al. Foot drop and plantar flexion failure determine different gait strategies in Charcot-Marie-Tooth patients. Clin Biomech (Bristol, Avon) 2007, 22:905-916.
8. Cook R.E., Schneider I., Hazlewood M.E., Hillman S.J., Robb J.E. Gait analysis alters decision-making in cerebral palsy. J Pediatr Orthop 2003, 23:292-295.
9. Fuller D.A., Keenan M.A., Esquenazi A., Whyte J., Mayer N.H., Fidler-Sheppard R. The impact of instrumented gait analysis on surgical planning: treatment of spastic equinovarus deformity of the foot and ankle. Foot Ankle Int 2002, 23:738-743.
10. Ferrarin M., Rabuffetti M., Ramella M., Osio M., Mailland E., Converti R.M. Does instrumented movement analysis alter, objectively confirm or not affect clinical decision-making in musicians with focal dystonia?. Med Prob Perform Artists 2008, 23(September (9)):99-106.
11. Mackey A.H., Walt S.E., Lobb G.A., Stott N.S. Reliability of upper and lower limb three-dimensional kinematics in children with hemiplegia. Gait Posture 2005, 22(August (1)):1-9.
12. Yavuzer G., Oken O., Elhan A., Stam H.J. Repeatability of lower limb three-dimensional kinematics in patients with stroke. Gait Posture 2008, 27(January (1)):31-35.
13. Fortin C., Nadeau S., Labelle H. Inter-trial test-retest reliability of kinematic kinetic gait parameters among subjects with adolescent idiopathic scoliosis. Eur Spine J 2008, 17(February (2)):204-216.
14. Ferrarin M., Rabuffetti M., Bovi G., Mazzoleni P., Montesano A., Pareyson D., et al. A multi-task gait analysis approach: normative data and pilot application to young CMT subjects. Proc. of 19th International Society for Posture and Gait Research Congress, ISPGR 2009 2009, 177.
15. Iosa M., Mazzà C., Frusciante R., Zok M., Aprile I., Ricci E., et al. Mobility assessment of patients with facioscapulohumeral dystrophy. Clin Biomech (Bristol, Avon) 2007, 22(December (10)):1074-1082.
16. Rabuffetti M., Crenna P. A modular protocol for the analysis of movement in children. Gait Posture 2004, 20:S77-S78.
17. Ferrarin M., Rizzone M., Lopiano L., Recalcati M., Pedotti A. Effects of subthalamic nucleus stimulation and L-dopa in trunk kinematics of patients with Parkinson's disease. Gait Posture 2004, 19(2):164-171.
18. Kadaba M.P., Ramakrishnan H.K., Wootten M.E., Gainey J., Gorton G., Cochran G.V.B. Repeatability of kinematic, kinetic, and electromyographic data in normal adult gait. J Orthop Res 1989, 7(6):849-860.
19. Weir J.P Quantifying test-retest reliability using the intraclass correlation coefficient and the SEM. J Strength Cond Res 2005, 19(1):231-240.
20. Portney L.G., Watkins M.P. Foundations of clinical research; application to practice 2000, Julie Alexander, Upper Saddle River. 2nd ed.
21. McGinley J.L., Baker R., Wolfe R., Morris M.E. The reliability of three-dimensional kinematic gait measurements: a systematic review. Gait Posture 2009, 29(April (3)):360-369.
22. Shy M.E., Blake J., Krajewski K., Fuerst D.R., Laura M., Hahn A.F., et al. Reliability and validity of the CMT neuropathy score as a measure of disability. Neurology 2005, 64(April (7)):1209-1214.
23. Graham R.C., Hughes R.A. A modified peripheral neuropathy scale: the Overall Neuropathy Limitations Scale. J Neurol Neurosurg Psychiatry 2006, 77(August (8)):973-976.
24. Graham R.C., Hughes R.A. Clinimetric properties of a walking scale in peripheral neuropathy. J Neurol Neurosurg Psychiatry 2006, 77(August (8)):977-979.
25. Solari A., Laurà M., Salsano E., Radice D., Pareyson D. Reliability of clinical outcome measures in Charcot-Marie-Tooth disease. Neuromuscul Disord 2008, 18(January (1)):19-26. CMT-TRIAAL Study Group.
26. Riener R., Rabuffetti M., Frigo C. Stair ascent and descent at different inclinations. Gait Posture 2002, 15(February (1)):32-44.